BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10360732)

  • 1. trans-2,6-,3,6- and 4,6-diaza-5,6,6a,7,8,12b-hexahydro-benzo[c]phenanthrene-10,11- diols as dopamine agonists.
    Gu YG; Bayburt EK; Michaelides MR; Lin CW; Shiosaki K
    Bioorg Med Chem Lett; 1999 May; 9(10):1341-6. PubMed ID: 10360732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands.
    Brewster WK; Nichols DE; Watts VJ; Riggs RM; Mottola D; Mailman RB
    J Med Chem; 1995 Jan; 38(2):318-27. PubMed ID: 7830274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
    Negash K; Nichols DE; Watts VJ; Mailman RB
    J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
    Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
    J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
    Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB
    J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. trans-hexahydroindolo[4,3-ab]phenanthridines ("benzergolines"), the first structural class of potent and selective dopamine D1 receptor agonists lacking a catechol group.
    Seiler MP; Hagenbach A; Wüthrich HJ; Markstein R
    J Med Chem; 1991 Jan; 34(1):303-7. PubMed ID: 1671417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the steric space at the floor of the D1 dopamine receptor orthosteric binding domain: 7α-, 7β-, 8α-, and 8β-methyl substituted dihydrexidine analogues.
    Cueva JP; Gallardo-Godoy A; Juncosa JI; Vidi PA; Lill MA; Watts VJ; Nichols DE
    J Med Chem; 2011 Aug; 54(15):5508-21. PubMed ID: 21714510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.
    Cueva JP; Chemel BR; Juncosa JI; Lill MA; Watts VJ; Nichols DE
    Eur J Med Chem; 2012 Feb; 48():97-107. PubMed ID: 22204903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
    Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
    J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
    Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
    J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands.
    Claudi F; Di Stefano A; Napolitani F; Cingolani GM; Giorgioni G; Fontenla JA; Montenegro GY; Rivas ME; Rosa E; Michelotto B; Orlando G; Brunetti L
    J Med Chem; 2000 Feb; 43(4):599-608. PubMed ID: 10691686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of D₁ receptor-agonist interactions and D₁/D₂ agonist selectivity using a combination of pharmacophore and receptor homology modeling.
    Malo M; Brive L; Luthman K; Svensson P
    ChemMedChem; 2012 Mar; 7(3):483-94, 338. PubMed ID: 22315216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and binding properties of several new dopaminergic ligands.
    Tuce Z; Soskić V; Joksimović J
    Drug Des Discov; 1994 Jun; 11(4):251-8. PubMed ID: 7727678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
    Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
    J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
    Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
    J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
    Doll MK; Nichols DE; Kilts JD; Prioleau C; Lawler CP; Lewis MM; Mailman RB
    J Med Chem; 1999 Mar; 42(5):935-40. PubMed ID: 10072690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
    Zhang J; Chen X; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2008 Nov; 16(21):9425-31. PubMed ID: 18835172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo.
    Michaelides MR; Hong Y; DiDomenico S; Bayburt EK; Asin KE; Britton DR; Lin CW; Shiosaki K
    J Med Chem; 1997 May; 40(11):1585-99. PubMed ID: 9171869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.